☆ 4.7 Article

Patient-derived organoids in ovarian cancer: Current research and its clinical relevance

BIOCHEMICAL PHARMACOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Engineering, Biomedical

Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids

Melissa C. Skala et al.

Summary: Patient-derived cancer organoids (PDCOs) are three-dimensional cultures grown from patient tumor samples, providing a valuable tool to study drug response and heterogeneity. Autofluorescence imaging is highlighted as a robust method to monitor the response of single cells and organoids.

ANNUAL REVIEW OF BIOMEDICAL ENGINEERING (2022)

添加到收藏夹

Article Oncology

The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells

Ziliang Wang et al.

Summary: This study found that FBN1 was significantly upregulated in cisplatin-resistant ovarian cancer, and it induces chemoresistance through its involvement in glycolysis and angiogenesis. The FBN1/VEGFR2/STAT2 signaling axis may serve as an inducer of chemoresistance in ovarian cancer cells.

CANCER COMMUNICATIONS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Gastrointestinal cancer organoids-applications in basic and translational cancer research

Therese Seidlitz et al.

Summary: Organoid technology allows for the generation of patient-derived models to better understand cancer biology, guide treatment selection, and study biological pathways contributing to tumor development and disease progression.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

添加到收藏夹

Article Genetics & Heredity

Mapping the temporal and spatial dynamics of the human endometrium in vivo and in vitro

Luz Garcia-Alonso et al.

Summary: Researchers have analyzed the dynamic changes of the human endometrium using single-cell and spatial transcriptomic profiling, revealing the regulatory role of WNT and NOTCH signaling pathways in differentiation into secretory and ciliated epithelial lineages.

NATURE GENETICS (2021)

添加到收藏夹

Review Oncology

Organoid and Spheroid Tumor Models: Techniques and Applications

Sreenivasulu Gunti et al.

Summary: 3D cell culture models like organoids and spheroids have unique advantages and applications, with organoids resembling the original tissue and being suitable for personalized medicine. Organoid-on-chip models combine organoid methods with micro-chip technology to simulate dynamic microenvironments.

CANCERS (2021)

添加到收藏夹

Article Cell Biology

Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis

Nur Yucer et al.

Summary: Germline pathogenic mutations in BRCA1 genes drive normal fallopian tube epithelial cell transformation to high-grade serous ovarian cancer. Induced pluripotent stem cells from individuals with these mutations show neoplastic transformation when differentiated into FTE organoids, indicating a potential value in predicting clinical severity prior to disease onset. This platform can be used for personalized mechanistic and drug screening studies.

CELL REPORTS (2021)

添加到收藏夹

Review Oncology

Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine

Camilla Nero et al.

Summary: This review discusses the current status and unmet needs in managing HGSOC, as well as available treatment options and biomarkers for clinical decisions. It also introduces organoid technology as a promising strategy for studying cancer and developing personalized therapies, with a focus on Patient's Derived Organoids (PDOs) for drug sensitivity testing. Despite promising results, efficient generation and expansion of organoids are needed to enable drug screening within a clinically relevant timeframe. Organoid-based clinical trials should offer tailored approaches to ovarian cancer management, recognizing the limitations of a one-size-fits-all approach in therapeutic advancements.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Medicine, General & Internal

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Usha Menon et al.

Summary: The long-term follow-up of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) did not show a significant reduction in deaths due to ovarian or tubal cancer with screening. While there was an increase in early-stage cancer detection in the MMS group, it did not translate into lives saved, highlighting the importance of specifying cancer mortality as the primary outcome in screening trials. Consequently, general population screening for ovarian and tubal cancer cannot be recommended.

LANCET (2021)

添加到收藏夹

Review Oncology

Patient-Derived Cancer Organoids as Predictors of Treatment Response

Maikel Verduin et al.

Summary: Patient-derived cancer organoids are valuable tools in predicting individualized treatment responses, comparing treatment efficacies, and screening new anti-cancer drugs. However, further improvements are needed to fully utilize the potential of cancer organoids in clinical cancer therapy management.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Biology

Self-organising human gonads generated by a Matrigel-based gradient system

Elizabeth Oliver et al.

Summary: The three-dimensional culture model generated organized whole gonadal organoids within 7 days. It provides a new opportunity to explore gonadal organogenesis and contributes to the development of more complex in vitro models in the field of developmental and regenerative medicine.

BMC BIOLOGY (2021)

添加到收藏夹

Article Oncology

The power and the promise of organoid models for cancer precision medicine with next-generation functional diagnostics and pharmaceutical exploitation

Yu-Shui Ma et al.

Summary: Cancer-derived organoids, derived from cancer tissue or cancer-specific stem cells, are ideal for simulating cancer characteristics and heterogeneity. They can be used for studying normal tissue physiology and in vitro cancer research, but have limitations such as the lack of nerves, blood vessels, and immune cells.

TRANSLATIONAL ONCOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer

Ryusuke Murakami et al.

Summary: By analyzing gene expression in ovarian cancer patients, this study identified biomarkers predictive of response to anti-PD-1 therapy. The clear cell and proliferative gene signatures showed significant differences between treatment response and disease progression, and combining these signatures improved prediction of clinical response.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Oncology

Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

Jianling Bi et al.

Summary: The study successfully established patient-derived organoid models (PDOs) for endometrial and ovarian cancer, providing a personalized and predictive treatment option for gynecologic cancer patients. Drug sensitivity testing using PDOs can predict patient responses to specific therapies, guiding clinical treatment decisions effectively.

CANCERS (2021)

添加到收藏夹

Review Cell Biology

Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities

Jiani Yang et al.

Summary: Ovarian cancer organoids provide a three-dimensional platform for research, helping to simulate biological characteristics and tumor heterogeneity, contributing to personalized therapy.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance

Justin W. Gorski et al.

Summary: The development of patient-derived tumor organoids from epithelial ovarian cancer has the potential to contribute significantly to precision medicine by testing chemotherapy sensitivity and investigating genetic drivers of drug resistance. This study identified one organoid line resistant to carboplatin, leading to a shorter progression-free survival and platinum-resistant recurrence. Gene expression analysis revealed interconnected pathways related to NF-kB, cellular differentiation, and B-cell receptor signaling in the context of carboplatin resistance.

BIOMEDICINES (2021)

添加到收藏夹

Article Oncology

Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response

Kankan Cao et al.

Summary: Tumor infiltrating mast cells (TIMs) play a role in prognosis and immunotherapy response in high-grade serous ovarian cancer (HGSOC), with high abundance of stromal TIMs associated with poor prognosis and immunoevasive subtype. Intensive inter-cell interactions between TIMs and other immune cells create an immunosuppressive microenvironment. A nomogram incorporating FIGO stage, sTIMs, and PD-L1 shows potential for predicting 5-year overall survival, outperforming the traditional FIGO staging system.

ONCOIMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine

Jin Qian et al.

Summary: Ovarian cancer-associated mesothelial cells play a critical role in promoting chemoresistance and stemness in ovarian cancer. The secreted factor osteopontin drives mesothelial-mediated chemoresistance and stemness, and therapeutic targeting of osteopontin may enhance platinum sensitivity in ovarian cancer.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Oncology

Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Changxin Wan et al.

Summary: This study demonstrates that the efficacy of immune therapies in high-grade serous ovarian cancer is driven by inducing state changes in NK cells and specific subsets of T cells. The results suggest that immune therapies, such as BRD1 inhibitors, capable of inducing such cellular state changes may have increased effectiveness in treating HGSC.

CANCER RESEARCH (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Scaffold-Free Endometrial Organoids Respond to Excess Androgens Associated With Polycystic Ovarian Syndrome

Teerawat Wiwatpanit et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

添加到收藏夹

Review Oncology

Organoid of ovarian cancer: genomic analysis and drug screening

H-D Liu et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment

Karen Hoffmann et al.

EMBO JOURNAL (2020)

添加到收藏夹

Review Oncology

Factors in Oncogenesis: Viral Infections in Ovarian Cancer

Sudipta Pathak et al.

CANCERS (2020)

添加到收藏夹

Article Oncology

Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma

Hui Chen et al.

GYNECOLOGIC ONCOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids

Kadi Lohmussaar et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Cell & Tissue Engineering

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models

Nina Maenhoudt et al.

STEM CELL REPORTS (2020)

添加到收藏夹

Article Genetics & Heredity

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer

Yann Kieffer et al.

FRONTIERS IN GENETICS (2020)

添加到收藏夹

Article Oncology

Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours

Dawn R. Cochrane et al.

JOURNAL OF PATHOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing

Yoshiko Nanki et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Cell Biology

Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses

Chris Jenske de Witte et al.

CELL REPORTS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma

Chao Lien Liu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages

Mei Song et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells

Huizhen Sun et al.

THERANOSTICS (2020)

添加到收藏夹

Article Cell Biology

Human fallopian tube epithelial cells exhibit stemness features, self-renewal capacity, and Wnt-related organoid formation

Yu-Hsun Chang et al.

JOURNAL OF BIOMEDICAL SCIENCE (2020)

添加到收藏夹

Review Cell Biology

PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms

Xuan Jiang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Chronic Chlamydia infection in human organoids increases stemness and promotes age-dependent CpG methylation

Mirjana Kessler et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

Oded Kopper et al.

NATURE MEDICINE (2019)

添加到收藏夹

Review Cell Biology

Current Status of Patient-Derived Ovarian Cancer Models

Yoshiaki Maru et al.

CELLS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma

Shuang Zhang et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Biology

A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids

Nhan Phan et al.

COMMUNICATIONS BIOLOGY (2019)

添加到收藏夹

Review Oncology

Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer

Angela Musella et al.

CANCER TREATMENT REVIEWS (2018)

添加到收藏夹

Article Cell & Tissue Engineering

Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression

Takashi Seino et al.

CELL STEM CELL (2018)

添加到收藏夹

Article Oncology

No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands

M. Timmermans et al.

EUROPEAN JOURNAL OF CANCER (2018)

添加到收藏夹

Review Oncology

Patient-derived tumor organoids for prediction of cancer treatment response

Peter W. Nagle et al.

SEMINARS IN CANCER BIOLOGY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer

Michela Coan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

添加到收藏夹

Article Oncology

Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Sarah J. Hill et al.

CANCER DISCOVERY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Organoid Modeling of the Tumor Immune Microenvironment

James T. Neal et al.

CELL (2018)

添加到收藏夹

Article Cell Biology

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer

Liya Ding et al.

CELL REPORTS (2018)

添加到收藏夹

Review Oncology

Organoids in cancer research

Jarno Drost et al.

NATURE REVIEWS CANCER (2018)

添加到收藏夹

Article Oncology

The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible

Eugenia Girda et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations

Julia Jabs et al.

MOLECULAR SYSTEMS BIOLOGY (2017)

添加到收藏夹

Article Cell Biology

Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium

Margherita Y. Turco et al.

NATURE CELL BIOLOGY (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

Disease Modeling in Stem Cell-Derived 3D Organoid Systems

Devanjali Dutta et al.

TRENDS IN MOLECULAR MEDICINE (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium

Nur Yucer et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Review Oncology

Niraparib in ovarian cancer: results to date and clinical potential

Davide Caruso et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Treatment of recurrent ovarian cancer

S. Pignata et al.

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Immunotherapy in ovarian cancer

K. Odunsi

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

Modeling Development and Disease with Organoids

Hans Clevers

CELL (2016)

添加到收藏夹

Review Medicine, Research & Experimental

Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment

Anselmo Papa et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2016)

添加到收藏夹

Review Cell Biology

Organoids as an in vitro model of human development and disease

Aliya Fatehullah et al.

NATURE CELL BIOLOGY (2016)

添加到收藏夹

Article Chemistry, Medicinal

Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination

Philip Jones et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Review Oncology

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

David D. Bowtell et al.

NATURE REVIEWS CANCER (2015)

添加到收藏夹

Article Cell Biology

Organoid cultures for the analysis of cancer phenotypes

Norman Sachs et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)

添加到收藏夹

Review Biochemistry & Molecular Biology

Epithelial ovarian cancer experimental models

E. Lengyel et al.

ONCOGENE (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Integrated genomic analyses of ovarian carcinoma

D. Bell et al.

NATURE (2011)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Advances in the preclinical testing of cancer therapeutic hypotheses

Giordano Caponigro et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

HE Bryant et al.

NATURE (2005)

添加到收藏夹

Article Multidisciplinary Sciences

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

H Farmer et al.

NATURE (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.